AirICU

A leading-edge mesh solution for intensive care

AiMesh® represents AirICU’s most advanced nebulization technology—developed through years of R&D and protected by an internationally certified invention patent. Designed specifically for high-demand clinical settings such as intensive care units, AiMesh® integrates intelligent nebulization algorithms with high-performance polymer mesh materials. This synergy delivers unmatched consistency, stability, and safety in drug delivery for patients.

Extensive validation behind AiMesh® technology

bench tests conducted across different drug formulations

Rigorous compatibility testing ensures broad adaptability with most inhaledmedications.

of iterative development and optimization

AiMesh has evolved through multiple engineering cycles for durability and precision.

of continuous atomization reliability tests

Proven long-term performance under intensive simulated clinical usage.

AirICU System Test Performance

1.AirICU System achieved top performance across all tested parameters, including:

2.AirICU demonstrated outstanding drug delivery efficiency, enabling effective deep lung deposition.

3.The system showed minimal medication waste and high delivery consistency across repeated use.

4.Technical metrics and clinical outcomes position AirICU as a preferred choice for nebulization therapy in intensive care settings.

A breakthrough in mesh design and materials

At the heart of AiMesh® is a custom-engineered polymer mesh designed with exceptional flexibility and durability. The mesh features a central outwardly curved structure embedded with annularly arranged micropores. These micropores are fixed into a hexagonal honeycomb configuration, which distributes stress evenly across the mesh. This unique design dramatically improves rupture resistance and extends device life.

Durability meets intelligent control

AiMesh® technology is supported by AI-driven algorithms that maintain consistent output under varying conditions, such as fluid viscosity, ambient temperature, and usage duration. The mesh material is medical-grade, biocompatible, and built to withstand prolonged operation without degradation. With no metal fatigue and minimal maintenance required, AiMesh® delivers both clinical-grade reliability and patient-friendly convenience—redefining what’s possible in nebulization therapy.

Engineered for high-performance drug delivery

The AirICU® series demonstrates outstanding efficiency when aerosolizing critical antibiotics such as Polymyxin and Tobramycin. Unlike conventional systems that exhibit rapid efficiency loss over time, AirICU® maintains a stable nebulization rate throughout the entire treatment course. This reliable output ensures more consistent drug deposition and therapeutic effect, even under continuous-use conditions commonly found in ICUs.

Validity

AirICU® ensures efficient drug delivery across IMV, NIV, and HF modes.

Workflow

AirICU® streamlines respiratory care.
As a closed-circuit system, it enables drug delivery during IMV and NIV without circuit interruption.
When paired with the iBreathe® Critical Care System, it offers a full solution—vital signs, nebulization status, history, and more.
AirICU® also supports integrated aerosol delivery during high-flow therapy.

Feedback

Efficient Therapy: Consistent fine mist delivery, suitable for neonatal and pediatric patients.
Clinician-Friendly: Intuitive control and real-time monitoring, improving safety and reducing workload.
Patient Comfort: Gentle and well-tolerated inhalation experience.
Hospital Value: Easy to manage and maintain.

Watch medical professionals share their views on AiMesh®